Triple Effect of Doxorubicin, 5-Fluorouracil, Propranolol on Cell Survival on MCF-7 Breast Cancer Cell Line

ISSN Print: 2327-5081
ISSN Online: 2327-509X
www.scirp.net/journal/jbm
E-mail: [email protected]

Citations

"Triple Effect of Doxorubicin, 5-Fluorouracil, Propranolol on Cell Survival on MCF-7 Breast Cancer Cell Line"
written by Onur Eroglu, Hacer Kaya, Esin Guvenir Celik, Merve Celen, Elif Korkut, Nagihan Nizam,
published by Journal of Biosciences and Medicines, Vol.7 No.2, 2019

has been cited by the following article(s):

[1]	Metal organic framework-based polymeric hydrogel: A promising drug delivery vehicle for the treatment of breast cancer
	International Journal of …, 2024

[2]	Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line
	Molecular Biology Reports, 2023

[3]	Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 cells
	2022

[4]	Antitumor activities of carboplatin–doxorubicin–ZnO complexes in different human cancer cell lines (breast, cervix uteri, colon, liver and oral) under UV exposition
	2021

[5]	In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting
	Iranian Journal of Basic Medical Sciences, 2021

[6]	Beyond the boundaries of cardiology: still untapped anticancer properties of the cardiovascular system-related drugs
	2019

[1]	Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/STAT5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line Molecular Biology Reports, 2022 DOI:10.1007/s11033-022-08034-4

[2]	Akrep Hemolenfinin Kanser Hücrelerinde Antiproliferatif ve Morfolojik Etkilerinin Araştırılması Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi, 2020 DOI:10.35193/bseufbd.682149